SMA drug Risdiplam approved by the FDA
The oral spinal muscular atrophy (SMA) drug Risdiplam has been approved by the FDA (U.S. Food and Drug Administration).
Read more-
Collagen VI-related myopathies research findings
05/08/2020Muscular Dystrophy UK has provided funding for Professors Muntoni and Bönneman for their project-work relating to collagen VI-related myopathies.
-
Muscular Dystrophy UK ‘Distance Aware’ badges
01/08/2020Many people in the muscular dystrophy community are very anxious about leaving their homes after this Saturday (August 1,) the date when the government has paused shielding.
-
Letter to editor- our experience of shielding
24/07/2020Pubs, restaurants and hair salons in England have been open for more than a week now as life slowly starts to return to normal for some.
-
-
Two big announcements on Changing Places Awareness Day
19/07/2020Two big announcements on Changing Places Awareness Day
-
Muscular Dystrophy UK and Healx announce partnership to identify FSHD treatments
15/07/2020MDUK and Healx announce new partnership to identify FSHD treatments
-
Muscular Dystrophy UK announced as charity partner of Wealdstone FC
02/07/2020We’re delighted to announce we will be the official charity partner of newly-promoted Wealdstone FC for the 2020/21 season.
-
AMRC calls on Government to match-fund charity research
25/06/2020AMRC calls on Government to match-fund charity research
-
Government updates guidance on shielding in England
22/06/2020The Government in England has set out its future plans for shielding for people at high risk of COVID-19.
-
